XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Marketable Securities
12 Months Ended
Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
3.
Marketable Securities

The following table summarizes the Company’s available-for-sale marketable securities as of December 31, 2022 and 2021 at net book value:

 

 

December 31, 2022

 

 

 

Amortized
Cost

 

 

Gross Unrealized
Gains

 

 

Gross Unrealized
Losses

 

 

Estimated Fair
Value

 

 

 

(In thousands)

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

$

244,562

 

 

$

62

 

 

$

(1,938

)

 

$

242,686

 

Financial institution debt securities

 

 

380,891

 

 

 

-

 

 

 

(1,030

)

 

 

379,861

 

Corporate debt securities

 

 

102,059

 

 

 

-

 

 

 

(509

)

 

 

101,550

 

Other asset-backed securities

 

 

14,703

 

 

 

-

 

 

 

(346

)

 

 

14,357

 

Total

 

$

742,215

 

 

$

62

 

 

$

(3,823

)

 

$

738,454

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2021

 

 

 

Amortized
Cost

 

 

Gross Unrealized
Gains

 

 

Gross Unrealized
Losses

 

 

Estimated Fair
Value

 

 

 

(In thousands)

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury and other government securities

 

$

301,493

 

 

$

-

 

 

$

(1,016

)

 

$

300,477

 

Financial institution debt securities

 

 

441,068

 

 

 

-

 

 

 

(652

)

 

 

440,416

 

Corporate debt securities

 

 

62,500

 

 

 

-

 

 

 

(151

)

 

 

62,349

 

Other asset-backed securities

 

 

159,707

 

 

 

-

 

 

 

(306

)

 

 

159,401

 

Total

 

$

964,768

 

 

$

-

 

 

$

(2,125

)

 

$

962,643

 

The amortized cost of available-for-sale securities is adjusted for amortization of premiums and accretion of discounts to maturity. At December 31, 2022 and 2021, the balance in the Company’s accumulated other comprehensive (loss)/income was composed of activity related to the Company’s available-for-sale marketable securities and equity method investment. There were no material realized gains or losses in the years ended December 31, 2022, 2021 or 2020. The Company did not reclassify any amounts out of accumulated other comprehensive income (loss) during these periods. The Company generally does not intend to sell any investments prior to recovery of their amortized cost basis for any investment in an unrealized loss position. As such, the Company has classified these losses as temporary in nature.

The Company's available-for-sale securities that are classified as short-term marketable securities in the consolidated balance sheet mature within one year or less as of the balance sheet date. Available-for-sale securities that are classified as noncurrent in the consolidated balance sheet are those that mature after one year but within five years from the balance sheet date and that the Company does not intend to dispose of within the next twelve months. At December 31, 2022 and 2021, the Company did not hold any investments that matured beyond five years of the balance sheet date.